Benzinga's Top Upgrades
- Wunderlich upgraded Arctic Cat Inc (NASDAQ: ACAT) from Sell to Hold. The price target for Arctic Cat is set to $13. Arctic Cat shares dropped 2.97 percent to close at $13.72 on Tuesday.
- Analysts at Citigroup upgraded Macy's Inc (NYSE: M) from Neutral to Buy. The price target for Macy's is set to $44. Macy's shares rose 2.36 percent to $35.50 in pre-market trading.
- Argus Research upgraded Las Vegas Sands Corp. (NYSE: LVS) from Hold to Buy. The price target for Las Vegas Sands is set to $67. Las Vegas Sands shares gained 1.26 percent to $57.25 in pre-market trading.
- Analysts at Jefferies upgraded Consolidated Edison, Inc. (NYSE: ED) from Hold to Buy. Consolidated Edison shares fell 1.64 percent to close at $73.23 on Tuesday.
- Bank of America upgraded Eldorado Gold Corp (USA) (NYSE: EGO) from Underperform to Buy. Eldorado Gold shares declined 3.46 percent to close at $3.63 on Tuesday.
- Analysts at Barrington Research upgraded DeVry Education Group Inc (NYSE: DV) from Market Perform to Outperform. DeVry Education shares rose 2.39 percent to $23.10 in pre-market trading.
- Stifel Nicolaus upgraded Potash Corporation of Saskatchewan (USA) (NYSE: POT) from Hold to Buy. Potash Corp shares rose 0.56 percent to $16.25 in pre-market trading.
- Oppenheimer upgraded F5 Networks, Inc. (NASDAQ: FFIV) from Perform to Outperform. F5 Networks shares rose 1.78 percent to $118.92 in pre-market trading.
- Analysts at Susquehanna upgraded Community Health Systems (NYSE: CYH) from Neutral to Positive. Community Health shares gained 5.29 percent to $11.35 in pre-market trading.
- Citigroup upgraded Intersil Corp (NASDAQ: ISIL) from Sell to Neutral. The price target for Intersil has been raised from $13.50 to $22.50. Intersil shares fell 0.55 percent to $21.58 in pre-market trading.
Latest Ratings for ACAT
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2017 | BMO Capital | Upgrades | Underperform | Market Perform |
Jan 2017 | Jefferies | Downgrades | Buy | Hold |
Jan 2017 | Wells Fargo | Downgrades | Market Perform | Underperform |
View More Analyst Ratings for ACAT
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: top upgradesUpgrades Analyst Ratings